Tevogen Bio Holdings Inc. (NASDAQ: TVGN)
$1.2900
N/A ( +1.58% ) 826.8K
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Market Data
Open
$1.2900
Previous close
$1.2900
Volume
826.8K
Market cap
$213.46M
Day range
$1.2000 - $1.4240
52 week range
$0.2556 - $21.0900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 68 | Aug 14, 2024 |
| 8-k | 8K-related | 15 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 13, 2024 |
| 8-k | 8K-related | 16 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 07, 2024 |
| 8-k/a | 8K-related | 15 | May 30, 2024 |
| 10-q | Quarterly Reports | 65 | May 28, 2024 |
| nt | Quarterly Reports | 1 | May 16, 2024 |
| 8-k | 8K-related | 14 | May 16, 2024 |
| 8-k | 8K-related | 15 | May 02, 2024 |